This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hien, T. T.
Right arrow Articles by Farrar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hien, T. T.
Right arrow Articles by Farrar, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2004, p. 4234-4239, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4234-4239.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria

T. T. Hien,1 T. M. E. Davis,2 L. V. Chuong,1 K. F. Ilett,3 D. X. T. Sinh,1 N. H. Phu,1 C. Agus,3 G. M. Chiswell,4 N. J. White,5,6 and J. Farrar5,6*

The Hospital for Tropical Diseases,1 University of Oxford-Wellcome Trust Clinical Research Unit, Centre for Tropical Diseases, Ho Chi Minh City, Vietnam,5 Medicine Unit, School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle,2 Pharmacology Unit, School of Medicine and Pharmacology, University of Western Australia, Crawley,3 Clinical Pharmacology and Toxicology Laboratory, The Western Australian Centre for Pathology and Medical Research, Nedlands, Australia,4 Centre for Tropical Diseases, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom6

Received 18 November 2003/ Returned for modification 25 April 2004/ Accepted 29 June 2004

The first-dose pharmacokinetic properties of intramuscular (i.m.) artesunate (ARTS; 2.4 mg/kg immediately [stat], followed by 1.2 mg/kg i.m. daily) and artemether (ARM; 3.2 mg/kg i.m. stat, followed by 1.6 mg/kg i.m. daily) were compared in Vietnamese adults with severe falciparum malaria. A total of 19 patients were studied; 9 received ARTS, and 10 received ARM. ARTS was absorbed very rapidly; concentrations in plasma peaked between 1,362 and 8,388 nmol/liter (median, 5,710 nmol/liter) within 20 min of injection and then declined with a median (range) half-life (t1/2) of 30 (3 to 67) min. ARTS was hydrolyzed rapidly and completely to the biologically active metabolite dihydroartemisinin (DHA). Peak DHA concentrations in plasma ranged between 1,718 and 7,080 nmol/liter (median, 3,060 nmol/liter) and declined with a t1/2 of 52 (26 to 69) min. In contrast, ARM was slowly and erratically absorbed. The absorption profile appeared biphasic. Maximum ARM concentrations in plasma ranged between 67 nmol/liter (a value close to the 50% inhibitory concentration for some Plasmodium falciparum isolates) and 1,631 nmol/liter (median, 574 nmol/liter) and occurred at a median (range) of 10 (1.5 to 24) h. There was relatively little conversion to DHA. After i.m. injection in cases of severe malaria, absorption of the water-soluble ARTS is rapid and extensive, whereas the oil-based ARM is slowly and erratically absorbed, with relatively little conversion to the more active DHA. On the basis of this pharmacological study, parenteral ARTS is preferable to ARM as an initial antimalarial therapy, particularly in the most seriously ill patients. These findings should be formally assessed by a randomized clinical trial.


* Corresponding author. Mailing address: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam. Phone: 0084-8-835-3954. Fax: 0084-8-835-3904. E-mail: jeremyjf{at}hcm.vnn.vn.


Antimicrobial Agents and Chemotherapy, November 2004, p. 4234-4239, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4234-4239.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Li, Q., Cantilena, L. R., Leary, K. J., Saviolakis, G. A., Miller, R. S., Melendez, V., Weina, P. J. (2009). Pharmacokinetic Profiles of Artesunate After Single Intravenous Doses at 0.5, 1, 2, 4, and 8 mg/kg in Healthy Volunteers: A Phase I Study. Am J Trop Med Hyg 81: 615-621 [Abstract] [Full Text]  
  • Sinou, V., Taudon, N., Mosnier, J., Aglioni, C., Bressolle, F. M. M., Parzy, D. (2008). Pharmacokinetics of artesunate in the domestic pig. J Antimicrob Chemother 62: 566-574 [Abstract] [Full Text]  
  • Bennett, K., Si, Y., Steinbach, T., Zhang, J., Li, Q. (2008). Pharmacokinetic and Pharmacodynamic Evaluation of Intramuscular Artesunate in Healthy Beagle Dogs. Am J Trop Med Hyg 79: 36-41 [Abstract] [Full Text]  
  • Rosenthal, P. J. (2008). Artesunate for the Treatment of Severe Falciparum Malaria. NEJM 358: 1829-1836 [Full Text]  
  • White, N. J. (2008). Qinghaosu (Artemisinin): The Price of Success. Science 320: 330-334 [Abstract] [Full Text]  
  • Keoluangkhot, V., Green, M. D., Nyadong, L., Fernandez, F. M., Mayxay, M., Newton, P. N. (2008). Impaired Clinical Response in a Patient with Uncomplicated Falciparum Malaria Who Received Poor-Quality and Underdosed Intramuscular Artemether. Am J Trop Med Hyg 78: 552-555 [Abstract] [Full Text]  
  • Day, N., Dondorp, A. M. (2007). The Management of Patients with Severe Malaria. Am J Trop Med Hyg 77: 29-35 [Abstract] [Full Text]  
  • Karunajeewa, H. A., Reeder, J., Lorry, K., Dabod, E., Hamzah, J., Page-Sharp, M., Chiswell, G. M., Ilett, K. F., Davis, T. M. E. (2006). Artesunate Suppositories versus Intramuscular Artemether for Treatment of Severe Malaria in Children in Papua New Guinea. Antimicrob. Agents Chemother. 50: 968-974 [Abstract] [Full Text]  
  • Pasvol, G. (2006). The treatment of complicated and severe malaria. Br Med Bull 75-76: 29-47 [Abstract] [Full Text]